Skip to main content

Celera Closes $195M Berkeley HeartLab Acquisition

NEW YORK (GenomeWeb News) — Celera said today it has closed its acquisition of Berkeley HeartLab for around $195 million in cash.
 
Celera said the acquisition, originally announced in early September, will begin to bring in accretive earnings in the second half of fiscal 2008.
  
Celera president Kathy Ordonez said the company was attracted to BHL for its existing products and for its potential to develop new predictive molecular diagnostics for cardiovascular disease.
 
BHL has around 300 employees, including 110 lab staffers and about 80 field-based representatives and clinical educators, Celera said.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.